Insider · CIK 0001826322

Virsik Peter

Reports to the SEC for 1 company · VANCOUVER, A1

sec.gov

Transactions

Companies

Filings

CIK

0001826322

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-10-07	EPIXESSA Pharma Inc.S Sale	Chief Operating Officer	SSale	−694 sh	$6.03	−$4,184.82	7,776
2024-09-09	EPIXESSA Pharma Inc.S Sale	Chief Operating Officer	SSale	−694 sh	$6.00	−$4,164	8,470
2024-09-03	EPIXESSA Pharma Inc.S Sale	Chief Operating Officer	SSale	−2,082 sh	$6.03	−$12.6K	9,164
2024-05-06	EPIXESSA Pharma Inc.S Sale	Chief Operating Officer	SSale	−694 sh	$6.95	−$4,823.3	11,246
2024-04-05	EPIXESSA Pharma Inc.S Sale	Chief Operating Officer	SSale	−694 sh	$7.94	−$5,510.36	11,940
2024-03-25	EPIXESSA Pharma Inc. · OptionsA Award	Chief Operating Officer	AAward	+110K sh	—	—	110,000
2024-03-05	EPIXESSA Pharma Inc.S Sale	Chief Operating Officer	SSale	−694 sh	$8.98	−$6,232.12	12,634
2024-02-06	EPIXESSA Pharma Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+72.8K sh	$3.23	+$235K	86,110
2024-02-06	EPIXESSA Pharma Inc.S Sale	Chief Operating Officer	SSale	−72.8K sh	$10.29	−$749K	13,328
2024-02-06	EPIXESSA Pharma Inc. · OptionsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−72.8K sh	—	—	895,000
2024-02-05	EPIXESSA Pharma Inc.S Sale	Chief Operating Officer	SSale	−694 sh	$9.25	−$6,419.5	13,328
2024-02-05	EPIXESSA Pharma Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+500 sh	$3.23	+$1,615	13,828
2024-02-05	EPIXESSA Pharma Inc.S Sale	Chief Operating Officer	SSale	−500 sh	$10.04	−$5,020	13,328
2024-02-05	EPIXESSA Pharma Inc. · OptionsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−500 sh	—	—	967,782
2024-01-16	EPIXESSA Pharma Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+1,718 sh	$3.23	+$5,549.14	15,740
2024-01-16	EPIXESSA Pharma Inc.S Sale	Chief Operating Officer	SSale	−1,718 sh	$10.01	−$17.2K	14,022
2024-01-16	EPIXESSA Pharma Inc. · OptionsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−1,718 sh	—	—	968,282
2024-01-05	EPIXESSA Pharma Inc.S Sale	Chief Operating Officer	SSale	−699 sh	$6.11	−$4,270.89	14,022
2022-06-29	EPIXESSA Pharma Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+90K sh	—	—	90,000
2020-12-11	EPIXESSA Pharma Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+200K sh	—	—	200,000

Recent filings

Accepted (ET)
Oct 74
Virsik Peter0000950170-24-113174
SEC(opens sec.gov)
Sep 94
Virsik Peter0000950170-24-104661
SEC(opens sec.gov)
Sep 34
Virsik Peter0000950170-24-103055
SEC(opens sec.gov)
May 64
Virsik Peter0000950172-24-000249
SEC(opens sec.gov)
Apr 54
Virsik Peter0000950172-24-000180
SEC(opens sec.gov)
Mar 284
Virsik Peter0000950172-24-000131
SEC(opens sec.gov)
Mar 54
Virsik Peter0001096906-24-000317
SEC(opens sec.gov)
Feb 74
Virsik Peter0001209191-24-002950
SEC(opens sec.gov)
Feb 64
Virsik Peter0001209191-24-002881
SEC(opens sec.gov)
Jan 174
Virsik Peter0001209191-24-001815
SEC(opens sec.gov)
Jan 84
Virsik Peter0001209191-24-001198
SEC(opens sec.gov)
Nov 14
Virsik Peter0001209191-22-054975
SEC(opens sec.gov)
Jan 114
Virsik Peter0001209191-21-002955
SEC(opens sec.gov)

Companies

ESSA Pharma Inc.Chief Operating OfficerEPIX

Address

C/O ESSA PHARMA INC. 999 WEST BROADWAY, SUITE 720

VANCOUVER, A1, V5Z 1K5